Cognitive and Quality of Life Impacts in Neuromyelitis Optica Spectrum Disorder

Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune astrocytopathy of the central nervous system that principally affects the optic nerves and spinal cord but also induces widespread microstructural and volumetric brain changes. Cognitive dysfunction is increasingly recognised in NMOSD, with impairments observed most commonly in memory, attention, information processing speed and executive control. These deficits may arise both from focal lesions and from diffuse alterations in white matter connectivity and deep grey matter structures. Beyond cognition, fatigue, pain and mood disturbance exert a profound negative influence on physical and mental quality of life (QoL). Patients frequently report sleep disruption, depressive symptoms and chronic pain syndromes that compound disability and reduce participation in daily activities. Advanced imaging techniques have begun to link specific microstructural changes—such as decreased fractional anisotropy and focal grey matter atrophy—to objective measures of cognitive performance and future disability progression. In clinical practice, systematic assessment of cognitive and QoL domains is essential for holistic management and for tailoring rehabilitation and psychosocial interventions that aim to preserve function and well-being.

Research from Nature Portfolio

Multimodal magnetic resonance imaging has been used to identify structural predictors of cognitive dysfunction in NMOSD. In a foundational study of over 70 patients, combined diffusion tensor imaging and volumetric analysis revealed that diffuse microstructural white matter damage and atrophy in deep grey matter nuclei—particularly the nucleus accumbens—were the strongest correlates of overall cognitive performance. Reduced fractional anisotropy in widespread white matter tracts and decreased volume of the thalamus and caudate were independently associated with deficits in attention, memory and executive function. These findings underscore the value of quantitative imaging biomarkers in predicting cognitive decline and guiding early intervention strategies.

Cognitive and Quality of Life Impacts in Neuromyelitis Optica Spectrum Disorder publication trend

The graph below shows the total number of articles in cognitive and quality of life impacts in neuromyelitis optica spectrum disorder across all publications each year (not limited to Nature Index journals).

Technical terms

Neuromyelitis optica spectrum disorder (NMOSD): A rare inflammatory autoimmune disorder targeting astrocytes, characterised by recurrent optic neuritis and transverse myelitis, often associated with aquaporin-4 antibodies.

Cognitive impairment: Deficits in cognitive processes—such as memory, attention, executive function and processing speed—that compromise daily activities and independence.

Quality of life (QoL): A multidimensional measure encompassing patients’ physical health, psychological state and social functioning as perceived by the individual.

Fractional anisotropy (FA): A scalar measure derived from diffusion tensor imaging that reflects the directional coherence of water diffusion in white matter tracts.

Expanded Disability Status Scale (EDSS): A clinician-rated scale ranging from 0 (normal) to 10 (death due to disease) quantifying neurological impairment and functional disability in demyelinating disorders.

References

1. Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder. Scientific Reports (2017).
2. In patients with mild disability NMOSD: is the alteration in the cortical morphological or functional network topological properties more significant. Frontiers in Immunology (2024).
3. A comprehensive review of the advances in neuromyelitis optica spectrum disorder. Autoimmunity Reviews (2023).
4. Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life. PLOS ONE (2017).